# Trazodone Once a Day in Major Depression Disorder

> **NCT02086929** · PHASE3 · COMPLETED · sponsor: **Aziende Chimiche Riunite Angelini Francesco S.p.A** · enrollment: 364 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Trazodone
- **DRUG:** Venlafaxine

## Key facts

- **NCT ID:** NCT02086929
- **Lead sponsor:** Aziende Chimiche Riunite Angelini Francesco S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 364 (ACTUAL)
- **Last updated:** 2015-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02086929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02086929, "Trazodone Once a Day in Major Depression Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02086929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*